Allen, and led now by interim-head Nader Pourhassan and Chief Scientific Officer Dr. Richard Trauger, CytoDyn epitomizes how many new medical therapies are developed today, in virtual (read, decentralized) laboratories, by companies with short ledger sheets, and armed with two or three sharp concepts with strong therapeutic and bottom-line potential.
FORBES: Progress in Drug Therapy Marks the 25th Anniversary of World AIDS Day